You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德AH股齊升超5%,在手訂單超預期
格隆匯 10-29 10:09
藥明康德績後走高,A股盤初一度升5%報56.15元,H股一度升超6%報56.1港元。公司昨晚發佈三季報表示,在外部環境挑戰下,公司收入和利潤均按計劃實現環比穩步提升,第三季度收入重回百億規模至104.61億元,剔除新冠商業化項目後同比增長14.6%。截至2024年9月底,藥明康德的在手訂單規模再創新高至438.2億元,同比增長35.2%,超市場預期。財報數據顯示,2024年前三季度藥明康德實現營業收入277.02億元,剔除新冠商業化項目後同比增長4.6%;歸母淨利潤65.33億元,經調整non-IFRS歸母淨利潤73.46億元;經營現金流剔除新冠商業化項目同比增長10.4%,增長持續快於收入增速;前三季度自由現金流達到55.6億元。對於全年業績,藥明康德預計與年初時所設目標一致,全年收入383-405億元,自由現金流60-70億元,以及經調整non-IFRS歸母淨利率保持與去年相當水平。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account